Related Experiment Video
Updated: Dec 23, 2025

A Murine Model of Hemodialysis Access-Related Hand Dysfunction
Published on: May 31, 2022
Association of Dysfunction of Vascular Access for Hemodialysis With Major Adverse Cardiovascular Events - A
Te-Hui Kuo1,2, Chin-Li Lu3, Ya-Hui Chang2
1Division of Nephrology, Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University.
Insights
Persistent dysfunction of hemodialysis vascular access significantly increases the risk of major adverse cardiovascular events (MACE). This finding aids in identifying high-risk patients for better cardiovascular event prevention in dialysis care.
Area of Science:
- Nephrology
- Cardiology
- Clinical Epidemiology
Background:
- Vascular access dysfunction is an unconventional risk factor for major adverse cardiovascular events (MACE) in hemodialysis patients.
- Previous studies identified this association, but clinical application requires intuitive risk stratification.
- Group-based trajectory modeling was employed to identify patients at highest risk for MACE.
Purpose of the Study:
- To identify and categorize hemodialysis patients based on vascular access dysfunction trajectories.
- To determine the association between different dysfunction patterns and the risk of subsequent MACE.
Main Methods:
- A cohort of 9,711 hemodialysis patients with MACE and 19,422 matched controls (2001-2010) were analyzed.
- Vascular access dysfunction events in the 6 months prior to MACE or index dates were evaluated.
- Group-based trajectory modeling categorized patients into no, escalating, or persistent dysfunction groups.
Main Results:
- Three patient groups were identified: no dysfunction (n=26,744), escalating dysfunction (n=650), and persistent dysfunction (n=1,739).
- Patients with persistent vascular access dysfunction (group 3) exhibited the highest risk of subsequent MACE.
- Logistic regression showed an odds ratio of 2.47 for MACE in group 3 compared to group 1, after adjusting for confounders.
Conclusions:
- Uninterrupted or persistent clusters of vascular access dysfunction are significantly associated with an elevated risk of subsequent MACE in hemodialysis patients.
- This trajectory-based approach offers a more intuitive method for identifying high-risk individuals for MACE.
- Targeting vascular access dysfunction management may be crucial for cardiovascular event prevention in dialysis populations.
Background:
An unconventional risk factor, "dysfunction of hemodialysis vascular access", was demonstrated to be associated with subsequent major adverse cardiovascular events (MACE) in our previous study. However, applying this suggestion in a clinical scenario may be not intuitive. A group-based trajectory model was applied to further recognize those patients with the highest risks for MACE.
Methods And Results:
In a cohort of patients who received hemodialysis from 2001 to 2010, we identified 9,711 cases that developed MACE in the stage of stable maintenance dialysis, and 19,422 randomly selected controls matched to cases on age, gender and duration of dialysis. Events of vascular access dysfunction in the 6-month period before MACE for cases and index dates for controls were evaluated. By group-based trajectory modeling, patients according to their counts of vascular access dysfunction in each month over the 6-month period prior to MACE or index dates were categorized. There were 26,744 patients in group 1 (no dysfunction), 650 in group 2 (escalating dysfunction) and 1,739 in group 3 (persistent dysfunction). Logistic regression analysis indicated that patients in group 3 had the highest chance of subsequent MACE (odds ratio 2.47, in comparison with group 1) after controlling for all the available potential confounders.
Conclusions:
Uninterrupted clusters of vascular access dysfunction are associated with a higher risk of subsequent MACE.
Related Concept Videos
Hemodialysis I: Introduction
Hemodialysis II: Procedure and Complications
Continuous Renal Replacement Therapy
Hemodialysis III: Nursing Management
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications
Cardiovascular Drugs: Classification based on Therapeutic Indications

